Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2012
06/28/2012WO2012058768A8 Stable heterodimeric antibody design with mutations in the fc domain
06/28/2012WO2012053828A9 Human interleukin-1 receptor antagonist - hybrid fc fusion protein
06/28/2012WO2012030137A3 Pharmaceutical composition for preventing or treating inflammatory diseases, allergic diseases or asthma, containing diospyros blancoi a. dc. extract as active ingredient
06/28/2012US20120165382 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
06/28/2012US20120165378 Thiophene-carboxamides useful as inhibitors of protein kinases
06/28/2012US20120165368 Pyrazolopyridine kinase inhibitors
06/28/2012US20120165367 Azaindazoles useful as inhibitors of kinases
06/28/2012US20120165362 Androgen receptor modulator compounds and methods
06/28/2012US20120165332 Sulfonamides and sulfamides as zap-70 inhibitors
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
06/28/2012US20120165328 Inhibitors of b lymphocyte kinase
06/28/2012US20120165327 Spiropiperidines for use as tryptase inhibitors
06/28/2012US20120165326 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro benzothiazoles and 5-fluoro benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
06/28/2012US20120165321 Quinoline derivatives as pi3 kinase inhibitors
06/28/2012US20120165319 Inhibitors of interleukin-1 beta converting enzyme
06/28/2012US20120165317 8-substituted benzoazepines as toll-like receptor modulators
06/28/2012US20120165311 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
06/28/2012US20120165309 Hetero ring derivative
06/28/2012US20120165307 Azaindoles useful as inhibitors of janus kinases
06/28/2012US20120165303 Triazolyl phenyl benzenesulfonamides
06/28/2012US20120165300 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
06/28/2012US20120165299 Combination medicament
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165285 Combined preparation for use as a medicament
06/28/2012US20120165277 Novel galactoside inhibitors of galectins
06/28/2012US20120165249 Stabilized Therapeutic Small Helical Antiviral Peptides
06/28/2012US20120164252 Supplement comprising blackcurrants or boysenberries
06/28/2012US20120164229 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
06/28/2012US20120164189 Lipidic Compositions for Induction of Immune Tolerance
06/28/2012US20120164181 Non-Specific Immunostimulating Agents
06/28/2012US20120164178 Vaccine
06/28/2012US20120164177 Rhinovirus vaccines
06/28/2012US20120164175 Novel influenza virus
06/28/2012US20120164173 Papilloma Pseudovirus and Preparation
06/28/2012US20120164172 Cancer Therapy
06/28/2012US20120164170 Porcine Circovirus Type 2 (PCV2), Immunogenic Composition Containing the Same, Test Kit, and Application Thereof
06/28/2012US20120164169 Bovine herpesvirus vaccine
06/28/2012US20120164168 B7-dc variants immunogenic compositions and methods of use thereof
06/28/2012US20120164167 Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof
06/28/2012US20120164166 Neisseria meningitidis antigens and compositions
06/28/2012US20120164165 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals
06/28/2012US20120164163 Cdc45l peptides and vaccines including the same
06/28/2012US20120164162 Methods in cell cultures, and related inventions, employing certain additives
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof
06/28/2012US20120164156 Recombinant F1-V Plague Vaccine
06/28/2012US20120164155 Chimeric molecules
06/28/2012US20120164153 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
06/28/2012US20120164152 Anti-il-17f antibodies and methods of use thereof
06/28/2012US20120164150 Monoclonal Antibodies Against Activated Protein C
06/28/2012US20120164147 Mammalian genes; related reagents and methods
06/28/2012US20120164145 H. pylori lipopolysaccharide outer core epitope
06/28/2012US20120164144 Novel anti-il13 antibodies and uses thereof
06/28/2012US20120164139 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
06/28/2012US20120164138 Use of anti-cd1 antibodies for the modulation of immune responses
06/28/2012US20120164132 Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
06/28/2012US20120164114 Treatment of immune-related diseases and disorders using amnion derived adherent cells
06/28/2012US20120164109 nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
06/28/2012US20120164108 Virus strains
06/28/2012US20120164107 Cyclic di-amp induction of type i interferon
06/28/2012US20120164103 Compounds and Methods for the Treatment or Prevention of Flavivirus Infections
06/28/2012US20120164099 Use of human prostate cell lines in cancer treatment
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012US20120164067 Methods of preventing or treating pain using anti-ngf antibodies that selectively inhibit the association of ngf with trka, without affecting the association of ngf with p75
06/28/2012DE102010063974A1 Preparing a radioactive fluorine substituted (1,2,4)oxadiazole compound, useful as radiodiagnostic to diagonize e.g. neurological and psychiatric disorders, comprises reacting a (1,2,4)oxadiazole compound with a radioactive fluorine
06/28/2012CA2822745A1 A composition comprising at least to compounds which induces indolamine 2,3-dioxygenase (ido), for the treatment of an autoimmune disorder or suffering from immune rejection of organs
06/28/2012CA2822639A1 Methods for treating systemic lupus erythematosus using hiv protease inhibitors
06/28/2012CA2822443A1 Modified influenza hemagglutinin proteins and uses thereof
06/28/2012CA2821574A1 Virus like particle production in plants
06/27/2012EP2468866A1 Biologically active oligonucleotides capable of modulating the immune system
06/27/2012EP2468865A1 Antisense oligonucleotide modulation of stat3 expression
06/27/2012EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/27/2012EP2468302A1 New indications for anti-IL-1beta therapy
06/27/2012EP2468301A1 New indications for anti-IL-1-beta therapy
06/27/2012EP2468284A1 Method of improving immune function in mammals using Lactobacillus strains with certain lipids
06/27/2012EP2468277A1 Triptolide derivatives for modulation of apoptosis and immunosuppression
06/27/2012EP2468260A2 Liposomes covered with the extracellular domain of the apo2l/trail protein
06/27/2012EP2467482A2 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
06/27/2012EP2467135A2 Desferrioxamine-metal complexes for the treatment of immune-related disorders
06/27/2012EP2467032A1 A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
06/27/2012EP1734946B1 Punicic acid for use to enhance immune response and treating inflammatory bowel disease
06/27/2012EP1698624B1 Phenylpropanoic acid derivatives
06/27/2012CN1826323B 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
06/27/2012CN102517292A Immunostimulatory oligoribonucleotides
06/27/2012CN102517253A In vitro amplification and low-temperature storage method for regulatory T cells of umbilical cord blood
06/27/2012CN102517252A Biological materials and uses thereof
06/27/2012CN102517190A Health care wine
06/27/2012CN102516383A Novel mite allergen
06/27/2012CN102516366A Th1 cell factor immunoregulation polypeptide and application thereof
06/27/2012CN102516263A Spirotricyclic compound, its preparation method, and pharmaceutical composition containing it as well as application thereof
06/27/2012CN102516247A A-type calcium L-5-methyltetrahydrofolate polymorphism and preparation method thereof
06/27/2012CN102516241A CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives
06/27/2012CN102516192A Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
06/27/2012CN102512675A Method for treating multiple sclerosis
06/27/2012CN102512673A Injectable artemisia pollen allergen vaccine and preparation method thereof
06/27/2012CN102512672A Artemisia pollen allergen vaccine and preparation method thereof
06/27/2012CN102512627A Traditional Chinese medicine composition for postoperative lung cancer
06/27/2012CN102512626A Medicinal composition for consolidation therapy after chemoradiotherapy on severe tumors and application thereof
06/27/2012CN102512615A Traditional Chinese medicinal composition used for cancer recovery stage
06/27/2012CN102512596A Traditional Chinese medicine for treating allergic purpura
1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 1172